Bioceres Crop Solutions Corp. (BIOX) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 4 Buy, 1 Hold.
The consensus price target is $2.00, representing an upside of 241.1% from the current price $0.59.
Analysts estimate Earnings Per Share (EPS) of $0.44 and revenue of $0.48B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.05 vs est $0.44 (missed -88.3%). 2025: actual $-0.82 vs est $-0.04 (missed -1950%). Analyst accuracy: 0%.
BIOX Stock — 12-Month Price Forecast
$2.00
▲ +241.12% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Bioceres Crop Solutions Corp., the price target is $2.00.
The average price target represents a +241.12% change from the last price of $0.59.
BIOX Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Bioceres Crop Solutions Corp. in the past 3 months
EPS Estimates — BIOX
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.05
vs Est $0.44
▼ 752.7% off
2025
Actual –$0.82
vs Est –$0.04
▼ 95.1% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.
Revenue Estimates — BIOX
93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.465B
vs Est $0.475B
▼ 2.2% off
2025
Actual $0.333B
vs Est $0.371B
▼ 11.2% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
